Constipation-Predominant Irritable Bowel Syndrome Clinical Trial Pipeline Highlights, 2019 - ResearchAndMarkets.com

DUBLIN--()--The "Global Constipation-Predominant Irritable Bowel Syndrome Clinical Trial Pipeline Highlights - 2019" report has been added to ResearchAndMarkets.com's offering.

Constipation-Predominant Irritable Bowel Syndrome Pipeline Highlights - 2019, provides most up-to-date information on key pipeline products in the global Constipation-Predominant Irritable Bowel Syndrome market. It covers emerging therapies for Constipation-Predominant Irritable Bowel Syndrome in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Constipation-Predominant Irritable Bowel Syndrome pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Constipation-Predominant Irritable Bowel Syndrome pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Constipation-Predominant Irritable Bowel Syndrome pipeline products by the company.

Short-term Launch Highlights:

Find out which Constipation-Predominant Irritable Bowel Syndrome pipeline products will be launched in the US and Ex-US till 2024.

Key Topics Covered:

1. Constipation-Predominant Irritable Bowel Syndrome Pipeline by Stages

2. Constipation-Predominant Irritable Bowel Syndrome Phase 3 Clinical Trial Insights

3. Constipation-Predominant Irritable Bowel Syndrome Phase 2 Clinical Trial Insights

4. Constipation-Predominant Irritable Bowel Syndrome Phase 1 Clinical Trial Insights

5. Constipation-Predominant Irritable Bowel Syndrome Preclinical Research Insights

6. Constipation-Predominant Irritable Bowel Syndrome Discovery Stage Insights

7. Appendix

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/5x6yu9

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Clinical Trials, Gastrointestinal Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Clinical Trials, Gastrointestinal Drugs